NLRP3 inflammasome activation and disruption of IRS-1/PI3K/AKT signaling: Potential mechanisms of arsenic-induced pancreatic beta cells dysfunction in rats

被引:2
作者
Liu, Yonglian [1 ]
Wang, Wenjuan [1 ]
Liang, Bing [1 ]
Zou, Zhonglan [1 ]
Zhang, Aihua [1 ]
机构
[1] Guizhou Med Univ, Sch Publ Hlth, Key Lab Environm Pollut Monitoring & Dis Control, Dept Toxicol,Minist Educ, Guiyang 550025, Guizhou, Peoples R China
关键词
Arsenic; Diabetes; Pancreatic beta cells; Insulin secretion; NLRP3; inflammasome; INSULIN-RESISTANCE; GLUCOSE; EXPOSURE; ASSOCIATION; OBESITY; INDIVIDUALS; INVOLVEMENT; METABOLISM; SECRETION;
D O I
10.1016/j.ecoenv.2024.117504
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Environmental exposure to arsenic is associated with significant health risks, including diabetogenic effects linked to pancreatic dysfunction. The NOD-like receptor protein 3 (NLRP3) inflammasome has been implicated in various metabolic abnormalities; however, its specific role in arsenic-induced pancreatic dysfunction remains insufficiently understood. This study aimed to elucidate the involvement and underlying mechanisms of the NLRP3 inflammasome in arsenic-induced pancreatic beta cells dysfunction through in vivo and in vitro models. In rat models, arsenic exposure was found to activate the NLRP3 inflammasome, as evidenced by pathomorphological changes and the expression of inflammasome activation markers. These pathological changes were accompanied by disruptions in the insulin signaling pathway, characterized by increased phosphorylation of insulin receptor substrate 1 (IRS-1) at Ser616, reduced expression of phosphatidylinositol 3-kinase (PI3K) and phosphorylated protein kinase B (AKT) at Ser473, and significant decreases in downstream targets, including the nuclear translocation of PDX-1, membrane translocation of glucose transporter 2 (GLUT2), and glucokinase (GCK) expression. In vitro, NaAsO2-treated INS-1 cells exhibited a dose-dependent reduction in glucosestimulated insulin secretion. Furthermore, arsenic exposure in these cells activated the NLRP3 inflammasome, suppressed the IRS-1/PI3K/AKT signaling pathway, and downregulated insulin secretion regulatory molecules (PDX-1, GLUT2, and GCK). Notably, these arsenic-induced effects were reversed by MCC950, an NLRP3 inflammasome inhibitor, and Extendin-4, an agonist of the IRS-1/PI3K/AKT signaling pathway. Collectively, these findings demonstrate that NLRP3 inflammasome activation disrupts the IRS-1/PI3K/AKT signaling pathway, contributing to arsenic-induced pancreatic beta cells dysfunction in rats.
引用
收藏
页数:14
相关论文
共 53 条
[1]   Insulin resistance and exendin-4 treatment for multiple system atrophy [J].
Bassil, Fares ;
Canron, Marie-Helene ;
Vital, Anne ;
Bezard, Erwan ;
Li, Yazhou ;
Greig, Nigel H. ;
Gulyani, Seema ;
Kapogiannis, Dimitrios ;
Fernagut, Pierre-Olivier ;
Meissner, Wassilios G. .
BRAIN, 2017, 140 :1420-1436
[2]   Increased interleukin (IL)-1β messenger ribonucleic acid expression in β-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation [J].
Boni-Schnetzler, Marianne ;
Thorne, Jeffrey ;
Parnaud, Geraldine ;
Marselli, Lorella ;
Ehses, Jan A. ;
Kerr-Conte, Julie ;
Pattou, Francois ;
Halban, Philippe A. ;
Weir, Gordon C. ;
Donath, Marc Y. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10) :4065-4074
[3]   HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects - Prospective data from the Verona Diabetes Complicated Study [J].
Bonora, E ;
Formentini, G ;
Calcaterra, F ;
Lombardi, S ;
Marini, F ;
Zenari, L ;
Saggiani, F ;
Poli, M ;
Perbellini, S ;
Raffaelli, A ;
Cacciatori, V ;
Santi, L ;
Targher, G ;
Bonadonna, R ;
Muggeo, M .
DIABETES CARE, 2002, 25 (07) :1135-1141
[4]   Long-Term Exposure to Low-Level Arsenic in Drinking Water and Diabetes Incidence: A Prospective Study of the Diet, Cancer and Health Cohort [J].
Brauner, Elvira Vaclavik ;
Nordsborg, Rikke Baastrup ;
Andersen, Zorana Jovanovic ;
Tjonneland, Anne ;
Loft, Steffen ;
Raaschou-Nielsen, Ole .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2014, 122 (10) :1059-1065
[5]   NLRP3 inflammasome and IL-1β pathway in type 2 diabetes and atherosclerosis: Friend or foe? [J].
Chen, Xu ;
Zhang, Dongxing ;
Li, Yuping ;
Wang, Weixuan ;
Bei, Weijian ;
Guo, Jiao .
PHARMACOLOGICAL RESEARCH, 2021, 173
[6]   Targeting innate immune mediators in type 1 and type 2 diabetes [J].
Donath, Marc Y. ;
Dinarello, Charles A. ;
Mandrup-Poulsen, Thomas .
NATURE REVIEWS IMMUNOLOGY, 2019, 19 (12) :734-746
[7]   Imbalanced inflammatory response in subchronic arsenic-induced liver injury and the protective effects of Ginkgo biloba extract in rats: Potential role of cytokines mediated cell-cell interactions [J].
Dong, Ling ;
Liu, Yonglian ;
Wang, Dapeng ;
Zhu, Kai ;
Zou, Zhonglan ;
Zhang, Aihua .
ENVIRONMENTAL TOXICOLOGY, 2021, 36 (10) :2073-2092
[8]   Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes [J].
Esser, Nathalie ;
Legrand-Poels, Sylvie ;
Piette, Jacques ;
Scheen, Andre J. ;
Paquot, Nicolas .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 105 (02) :141-150
[9]   The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages [J].
Evavold, Charles L. ;
Ruan, Jianbin ;
Tan, Yunhao ;
Xia, Shiyu ;
Wu, Hao ;
Kagan, Jonathan C. .
IMMUNITY, 2018, 48 (01) :35-+
[10]   The role of interleukins in insulin resistance and type 2 diabetes mellitus [J].
Feve, Bruno ;
Bastard, Jean-Philippe .
NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (06) :305-311